Login to Your Account


NEW CRL PUTS OXYCODONE IN PARKED PLACE

CEO Remi Barbier said Pain Therapeutics Inc. will ask for an SPA with regard to new trials demanded by the FDA's third complete response letter  for extended-release, abuse-deterrent Remoxy (oxycodone). more »


Opinion


Partners in Focus